MedTrace Logo

Robot Assisted Gait Training In Children With Cerebral Palsy

NCT05540990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2024-02-08

No results posted yet for this study

Summary

Cerebral Palsy (CP) is considered a neurological disorder caused by a non-progressive brain injury or malformation that occurs while the child's brain is under development. CP primarily affects body movement and muscle coordination. Robot assisted gait training (RAGT) is considered to be a promising approach for improving gait related gross motor function of children and youth with CP.

There is weak and inconsistent evidence regarding the use of RAGT for children with gait disorders. Further research is required with increased numbers and with relevant outcome measures to both confirm the effectiveness and clarify training schedules.

The aim of this research project is to investigate the effectiveness of robot assisted gait training on improvements of functional gait parameters in children with cerebral palsy.

Conditions

  • Cerebral Palsy
  • Physical Therapy
  • Robotic Rehabilitation
  • Motor Skills Disorders

Interventions

DEVICE

Robot assisted gait training

15 sessions of robot-assisted gait training (two times per week with a maximum of 45 minute each).

OTHER

Conventional physiotherapy

individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Birkan Sonel Tur, Prof · Ankara University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2023-07-26
Completion
2023-07-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540990 on ClinicalTrials.gov